These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
56 related articles for article (PubMed ID: 9693447)
1. For diabetes: a preprandial pill .. Health News; 1998 Jul; 4(9):5. PubMed ID: 9693447 [No Abstract] [Full Text] [Related]
2. Comments on type 2 diabetes screening and treatment. Kolaczynski JW Am Fam Physician; 2000 Jan; 61(1):49-50. PubMed ID: 10643950 [No Abstract] [Full Text] [Related]
3. Treating type 2 diabetes. When diet and exercise aren't enough, a broad range of medications can help control our blood sugar. Blackburn GL Health News; 2004 Aug; 10(8):4-5. PubMed ID: 15551454 [No Abstract] [Full Text] [Related]
4. Repaglinide: a short acting insulin secretagogue for postprandial hyperglycaemia. Ambavane V; Patil R; Ainapure SS J Postgrad Med; 2002; 48(3):246-8. PubMed ID: 12432213 [No Abstract] [Full Text] [Related]
5. The role of prandial glucose regulation with repaglinide in addressing the problem of hypoglycemia in the treatment of type 2 diabetes. Owens D J Assoc Physicians India; 2001 Jan; 49 Spec No():54-61. PubMed ID: 11235607 [No Abstract] [Full Text] [Related]
7. Oral combination therapy: repaglinide plus metformin for treatment of type 2 diabetes. Raskin P Diabetes Obes Metab; 2008 Dec; 10(12):1167-77. PubMed ID: 18494804 [TBL] [Abstract][Full Text] [Related]
8. [Antidiabetic drug at every meal. Repaglinide is especially recommended for slender type 2 diabetic patients]. Landgraf R MMW Fortschr Med; 2000 Jul; 142(28-29):29-30. PubMed ID: 10959157 [TBL] [Abstract][Full Text] [Related]
9. Type 2 diabetes management. Nelson G Br J Community Nurs; 2002 Jan; 7(1):5. PubMed ID: 11823724 [No Abstract] [Full Text] [Related]
11. [symbol: see text] Nateglinide and [symbol: see text] repaglinide for type 2 diabetes? Drug Ther Bull; 2003 Jul; 41(7):52-4. PubMed ID: 12879789 [TBL] [Abstract][Full Text] [Related]
13. Drugs for type 2 diabetes. Treat Guidel Med Lett; 2008 Jul; 6(71):47-54. PubMed ID: 18583949 [No Abstract] [Full Text] [Related]
14. Modification of beta-cell response to different postprandial blood glucose concentrations by prandial repaglinide and combined acarbose/repaglinide application. Rosak C; Hofmann U; Paulwitz O Diabetes Nutr Metab; 2004 Jun; 17(3):137-42. PubMed ID: 15334790 [TBL] [Abstract][Full Text] [Related]
15. Repaglinide plus single-dose insulin glargine: a safe regimen for low-risk type 2 diabetic patients who insist on fasting in Ramadan. Bakiner O; Ertorer ME; Bozkirli E; Tutuncu NB; Demirag NG Acta Diabetol; 2009 Mar; 46(1):63-5. PubMed ID: 18825302 [TBL] [Abstract][Full Text] [Related]
16. Repaglinide induced acute hepototoxicity. Jaiswal S; Mehta R; Musuku M; Tran L; McNamee W JNMA J Nepal Med Assoc; 2009; 48(174):162-4. PubMed ID: 20387361 [TBL] [Abstract][Full Text] [Related]
17. Honing type 2 diabetes treatment. Blackburn G Health News; 2001 Jan; 7(1):1-2. PubMed ID: 11198405 [No Abstract] [Full Text] [Related]
18. [Flexible oral therapy of diabetes mellitus type 2: dietary glucose regulation as therapeutic principle. 34th annual session of the European Association for the Study of Diabetes (EASD). Barcelona, 8-12 September 1998]. Dtsch Med Wochenschr; 1998 Dec; 123(50 Suppl Flexible):1-4. PubMed ID: 9883267 [No Abstract] [Full Text] [Related]